Delivery Order SPE2DB22D9112-SPE2DB24FE6PC
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $6,189.60 by the Defense Logistics Agency to provide 150 milligrams per milliliter syringes of Xolair. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency Troop Support Medical to provide Xolair 150 mg/ml syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply needed pharmaceutical items and medical products to military treatment centers supported by the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $6,189.60 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,568.80 by the Defense Logistics Agency to provide XOLAIR 150 MG/ML SYRINGEML. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business and woman-owned entity, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $23,984.70 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150MG/ML SYR 1S. The delivery order has a completion date of December 12, 2023 and was awarded on the same date by the Defense Logistics Agency Troop Support Medical. DMS Pharmaceutical Group Inc. will fulfill the delivery order from its location in Park Ridge, Illinois. As a woman-owned small business and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $4,642.20 against its indefinite delivery contract with the Defense Logistics Agency to supply 150 milligrams per milliliter syringes of Xolair. The delivery order has no set-aside designation and requires completion by December 1, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency through December 2025 to provide various pharmaceutical and medical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents ($11,605.50) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group will deliver...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $77,370 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. As a woman owned small business and woman owned business, DMS Pharmaceutical Group will deliver the pharmaceutical products to Park Ridge, Illinois by December 2023. DMS Pharmaceutical Group currently supplies various medical supplies and pharmaceuticals to support military treatment facilities...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,568.80 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS Pharmaceutical...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB24FE6PCDelivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $6,189.60 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. Performance will take place in Park Ridge, Illinois and is scheduled for completion by December 4, 2023. DMS Pharmaceutical Group is a woman-owned small business that has held numerous contracts with the Defense Logistics Agency to directly supply prescription medications and medical products to support the operation of military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/9/23 |